Загрузка...
Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure
BACKGROUND: Beta-blocker therapy has become a mainstay therapy for the over 5 million patients with chronic heart failure in the United States. Variation in clinical response to β-blockers is a well-known phenomenon and may be because of genetic differences between patients. We hypothesized that var...
Сохранить в:
| Главные авторы: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3035051/ https://ncbi.nlm.nih.gov/pubmed/18953265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e328317cc57 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|